Amgen commercializes Stowers osteoporosis discovery
The guest highlighted a successful research monetization pathway where the Stowers Institute discovered a biological mechanism to reverse osteoporosis and sold the technology to Amgen.
The argument
The guest discussed how the non-profit Stowers Institute for Medical Research, funded by asset management firm American Century, collaborates with and sells discoveries to commercial pharmaceutical companies. Specifically, they discovered a mechanism in fish that not only slows but reverses osteoporosis, which was subsequently acquired and commercialized by Amgen.
The thesis, stress-tested
✓ What validates it
- ✓Clinical trial data updates or revenue milestones reported by Amgen regarding its osteoporosis treatments
▸ Risks discussed
- ▸Clinical development and regulatory approval risks for licensed compounds
- ▸Dependence on basic science discoveries translating to human biology
Hear it yourself
"American Century is a Kansas City based asset manager with over 300,000,000,000 in assets whose ownership structure directs much of its profits to the Stowers Institute for Medical Research."
00:00 / 00:15
AFFILIATE LINK · ZORTIX MAY EARN A COMMISSION · NEVER A RECOMMENDATION TO TRADE